{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:26:07Z","timestamp":1790616367084,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148095","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T13:56:55Z","timestamp":1454335015000},"page":"e0148095","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity"],"prefix":"10.1371","volume":"11","author":[{"given":"Christine","family":"Pich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iotefa","family":"Teiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Sarrabayrouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Gence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fran\u00e7oise","family":"Tilkin-Mariam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"M Holderfield","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11912-012-0249-5","article-title":"Driver mutations in melanoma: lessons learned from bench-to-bedside studies","volume":"14","author":"JM Mehnert","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","article-title":"Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies","volume":"12","author":"G Saldanha","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"259170","DOI":"10.1155\/2012\/259170","article-title":"Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma","volume":"2012","author":"F Ades","year":"2012","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PPO.0000000000000024","article-title":"A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States","volume":"20","author":"L Flaherty","year":"2014","journal-title":"Cancer J"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","article-title":"BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma","volume":"19","author":"DT Frederick","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"e22890","DOI":"10.4161\/onci.22890","article-title":"Vemurafenib enhances MHC induction in BRAF homozygous melanoma cells","volume":"2","author":"B Sapkota","year":"2013","journal-title":"Oncoimmunology"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/clpt.2013.197","article-title":"Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapies","volume":"95","author":"S Jang","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","article-title":"Melanoma-expressed C70 is involved in invasion and metastasis","author":"CS G Pich","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2009.00774.x","article-title":"Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology","volume":"229","author":"MA Nolte","year":"2009","journal-title":"Immunol Rev"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1189\/jlb.0610351","article-title":"Role of CD27\/CD70 pathway of activation in immunity and tolerance","volume":"89","author":"J Denoeud","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1189\/jlb.1003508","article-title":"Signalling via CD70, a member of the TNF family, regulates T cell functions","volume":"76","author":"P Garcia","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.cgt.7700861","article-title":"Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity","volume":"12","author":"C Cormary","year":"2005","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1158\/0008-5472.CAN-04-4395","article-title":"Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70","volume":"65","author":"A Chahlavi","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.humpath.2011.10.014","article-title":"CD70 expression patterns in renal cell carcinoma","volume":"43","author":"LB Jilaveanu","year":"2012","journal-title":"Hum Pathol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1096\/fj.04-3482fje","article-title":"Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression","volume":"19","author":"AF Tilkin-Mariame","year":"2005","journal-title":"FASEB J"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1593\/neo.07727","article-title":"Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA\/ROCK pathway in murine melanoma cells","volume":"9","author":"G Sarrabayrouse","year":"2007","journal-title":"Neoplasia"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e9043","DOI":"10.1371\/journal.pone.0009043","article-title":"Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells","volume":"5","author":"G Sarrabayrouse","year":"2010","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-442-1_1","article-title":"Historical overview of Rho GTPases","volume":"827","author":"AJ Ridley","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"14","key":"ref20","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.febslet.2008.04.039","article-title":"Rho GTPases in cancer cell biology","volume":"582","author":"FM Vega","year":"2008","journal-title":"FEBS Lett"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.4049\/jimmunol.174.10.6212","article-title":"Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs","volume":"174","author":"Q Lu","year":"2005","journal-title":"J Immunol"},{"issue":"Pt 2","key":"ref22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj20020844","article-title":"Small interfering RNAs as a tool to assign Rho GTPase exchange-factor function in vivo","volume":"366","author":"A Gampel","year":"2002","journal-title":"Biochem J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-61779-442-1_19","article-title":"Use of phage display for the identification of molecular sensors specific for activated Rho","volume":"827","author":"P Chinestra","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"e101963","DOI":"10.1371\/journal.pone.0101963","article-title":"Plasticity of the MAPK signaling network in response to mechanical stress","volume":"9","author":"AM Pereira","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.humpath.2012.03.031","article-title":"Expression of the vitamin D-activating enzyme 1alpha-hydroxylase (CYP27B1) decreases during melanoma progression","volume":"44","author":"AA Brozyna","year":"2013","journal-title":"Hum Pathol"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/bjc.2011.458","article-title":"High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives","volume":"105","author":"Z Janjetovic","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.jid.5700211","article-title":"RhoC promotes human melanoma invasion in a PI3K\/Akt-dependent pathway","volume":"126","author":"MC Ruth","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.ejca.2008.04.009","article-title":"Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation","volume":"44","author":"P Dua","year":"2008","journal-title":"Eur J Cancer"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/bjc.2014.99","article-title":"Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer","volume":"110","author":"M Brown","year":"2014","journal-title":"Br J Cancer"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/14728222.12.3.341","article-title":"CD70 as a therapeutic target in human malignancies","volume":"12","author":"IS Grewal","year":"2008","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1359\/jbmr.081240","article-title":"ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK","volume":"24","author":"CB Khatiwala","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-4598-10-118","article-title":"BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study","volume":"10","author":"E Makrodouli","year":"2011","journal-title":"Mol Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T01:18:49Z","timestamp":1567559929000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148095"}},"subtitle":[],"editor":[{"given":"Andrzej T","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148095","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}